ROMIDEPSIN

romidepsin 10 mg injection [1 vial] (&) inert substance diluent [2 mL vial], 1 pack

ROMIDEPSIN (15370Y)

romidepsin 10 mg injection [1 vial] (&) inert substance diluent [2 mL vial], 1 pack
15370Y
Body System:
Manner of administration:Injection
Public
Chemotherapy Items for Public Hospital use
Authority Required

Restriction

Indication: Relapsed or chemotherapy refractory Peripheral T-cell Lymphoma
Treatment phase: Continuing treatment

Restriction

Indication: Relapsed or chemotherapy refractory Peripheral T-cell Lymphoma
Treatment phase: Grandfather arrangement - Transitioning from non-PBS-subsidised treatment
Quantities & Cost
Max amount # of repeats DPMA Max safety net General Patient Charge
Max amount: 40 mg # of repeats: 8 DPMA: $4,985.64 Max safety net: $25.00 General Patient Charge: $25.00
Available brands
ROMIDEPSIN-REACH
(romidepsin 10 mg injection [1 vial] (&) inert substance diluent [2 mL vial], 1 pack)